Xu ZG - Search Results

1

[Clinicopathological features and BRAF V600E and MYD88 L265P mutation status of nodal marginal zone lymphoma].

Wang XY, Li M, Zhao YX, Wang LF, Li DJ, Xu ZG, Kong LF. Wang XY, et al. Among authors: xu zg. Zhonghua Bing Li Xue Za Zhi. 2022 Apr 8;51(4):301-306. doi: 10.3760/cma.j.cn112151-20211220-00915. Zhonghua Bing Li Xue Za Zhi. 2022. PMID: 35359040 Chinese.

2

[Clinicopathologic characteristic of oncocytic mucoepidermoid carcinoma: report of 8 cases].

Ren Y, Kong LF, Zhang MY, Li DJ, Xu ZG, Kan YZ, Yin PZ. Ren Y, et al. Among authors: xu zg. Zhonghua Bing Li Xue Za Zhi. 2017 Jul 8;46(7):499-500. doi: 10.3760/cma.j.issn.0529-5807.2017.07.011. Zhonghua Bing Li Xue Za Zhi. 2017. PMID: 28728226 Chinese. No abstract available.

3

[Clinicopathologic and genetic features analysis of oral and maxillofacial metastatic carcinoma].

Liu QY, Zhang YP, Xu ZG, Gao G, Feng SE, Kong LF, Wang YG. Liu QY, et al. Among authors: xu zg. Zhonghua Bing Li Xue Za Zhi. 2018 Jul 8;47(7):546-547. doi: 10.3760/cma.j.issn.0529-5807.2018.07.014. Zhonghua Bing Li Xue Za Zhi. 2018. PMID: 29996323 Chinese. No abstract available.

4

CCAAT/Enhancer Binding Protein β-Mediated MMP3 Upregulation Promotes Esophageal Squamous Cell Cancer Invasion In Vitro and Is Associated with Metastasis in Human Patients.

Li H, Yang F, Chai L, Zhang L, Li S, Xu Z, Kong L. Li H, et al. Genet Test Mol Biomarkers. 2019 May;23(5):304-309. doi: 10.1089/gtmb.2018.0291. Epub 2019 Apr 10. Genet Test Mol Biomarkers. 2019. PMID: 30969151

5

[Calcifying fibrous tumor: a clinicopathological analysis of 32 cases].

Zhang L, Wei JG, Fang SG, Luo RK, Xu ZG, Li DJ, Kong LF. Zhang L, et al. Among authors: xu zg. Zhonghua Bing Li Xue Za Zhi. 2020 Feb 8;49(2):129-133. doi: 10.3760/cma.j.issn.0529-5807.2020.02.005. Zhonghua Bing Li Xue Za Zhi. 2020. PMID: 32074724 Chinese.

6

[Extranodal nasal-type natural killer/T-cell lymphoma with aberrant expression of CD20: two cases report and literature review].

Li DJ, Kan YZ, Xu ZG, Kang H, Dong XM, Kong LF. Li DJ, et al. Among authors: xu zg. Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):336-339. doi: 10.3760/cma.j.issn.0253-2727.2020.04.016. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 32447942 Free PMC article. Review. Chinese. No abstract available.

7

Incidence and PD-L1 Expression of MET 14 Skipping in Chinese Population: A Non-Selective NSCLC Cohort Study Using RNA-Based Sequencing.

Xu Z, Li H, Dong Y, Cheng P, Luo F, Fu S, Gao M, Kong L, Che N. Xu Z, et al. Onco Targets Ther. 2020 Jun 30;13:6245-6253. doi: 10.2147/OTT.S241231. eCollection 2020. Onco Targets Ther. 2020. PMID: 32669854 Free PMC article.

8

[Role of up-regulated DDX3 in the proliferation of human cervical cancer cells].

Guo FF, Zhao RJ, Li DJ, Xu ZG, Kong LF. Guo FF, et al. Among authors: xu zg. Zhonghua Bing Li Xue Za Zhi. 2021 Feb 8;50(2):119-124. doi: 10.3760/cma.j.cn112151-20200519-00394. Zhonghua Bing Li Xue Za Zhi. 2021. PMID: 33535306 Chinese.

9

NRF1-regulated CircNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1.

Wang L, Yang B, Xu Z, Song X, Gong Z, Xue S, Kong L. Wang L, et al. Cell Cycle. 2021 May;20(9):819-828. doi: 10.1080/15384101.2021.1897272. Epub 2021 Apr 16. Cell Cycle. 2021. PMID: 33858292 Free PMC article.

10

Predicting factors of central lymph node metastasis and BRAF^V600E mutation in Chinese population with papillary thyroid carcinoma.

Zhou SL, Guo YP, Zhang L, Deng T, Xu ZG, Ding C, Sun WC, Zhao YW, Kong LF. Zhou SL, et al. Among authors: xu zg. World J Surg Oncol. 2021 Jul 13;19(1):211. doi: 10.1186/s12957-021-02326-y. World J Surg Oncol. 2021. PMID: 34256769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters